1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C20orf194 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA HLA-DOB CTRPv2 pan-cancer AAC -0.12 0.002
mRNA C15orf38-AP3S2 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA RAB39B CTRPv2 pan-cancer AAC 0.12 0.002
mRNA MT-ATP6 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA PCDHA9 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA VDAC1 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA NCALD CTRPv2 pan-cancer AAC 0.11 0.002
mRNA DAGLA CTRPv2 pan-cancer AAC 0.12 0.002
mRNA PWP1 CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV